| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Histogen Inc. | Executive Vice President and Chief Scientific Officer | Stock Option (right to buy) | 106,793 | 23 Feb 2023 | Direct | ||
| Histogen Inc. | Executive Vice President and Chief Scientific Officer | Common Stock | 1,235 | 01 Feb 2023 | Indirect | ||
| Histogen Inc. | Executive Vice President and Chief Scientific Officer | Common Stock | 979 | 01 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123013183-spada-alfred-p-2023-02-23 | Histogen Inc. | 23 Feb 2023 | 1 | $0 | 4 | Executive Vice President and Chief Scientific Officer | 27 Feb 2023, 15:18 |
| /report/000120919123006844-spada-alfred-p-2023-02-01 | Histogen Inc. | 01 Feb 2023 | 0 | $0 | 3 | Executive Vice President and Chief Scientific Officer | 03 Feb 2023, 15:22 |